Cargando…
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678580/ https://www.ncbi.nlm.nih.gov/pubmed/33216224 http://dx.doi.org/10.1007/s00415-020-10310-x |
| _version_ | 1783612186511278080 |
|---|---|
| author | Wanschitz, Julia V. Kaml, Manuela Pfausler, Bettina Helbok, Raimund Wildner, Sophie Widmann, Gerlig Sahanic, Sabina Deisenhammer, Florian Löscher, Wolfgang N. Reindl, Markus Löffler-Ragg, Judith Beer, Ronny |
| author_facet | Wanschitz, Julia V. Kaml, Manuela Pfausler, Bettina Helbok, Raimund Wildner, Sophie Widmann, Gerlig Sahanic, Sabina Deisenhammer, Florian Löscher, Wolfgang N. Reindl, Markus Löffler-Ragg, Judith Beer, Ronny |
| author_sort | Wanschitz, Julia V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7678580 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76785802020-11-23 Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up Wanschitz, Julia V. Kaml, Manuela Pfausler, Bettina Helbok, Raimund Wildner, Sophie Widmann, Gerlig Sahanic, Sabina Deisenhammer, Florian Löscher, Wolfgang N. Reindl, Markus Löffler-Ragg, Judith Beer, Ronny J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-11-20 2021 /pmc/articles/PMC7678580/ /pubmed/33216224 http://dx.doi.org/10.1007/s00415-020-10310-x Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editors Wanschitz, Julia V. Kaml, Manuela Pfausler, Bettina Helbok, Raimund Wildner, Sophie Widmann, Gerlig Sahanic, Sabina Deisenhammer, Florian Löscher, Wolfgang N. Reindl, Markus Löffler-Ragg, Judith Beer, Ronny Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| title | Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| title_full | Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| title_fullStr | Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| title_full_unstemmed | Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| title_short | Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| title_sort | myasthenic crisis following sars-cov-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678580/ https://www.ncbi.nlm.nih.gov/pubmed/33216224 http://dx.doi.org/10.1007/s00415-020-10310-x |
| work_keys_str_mv | AT wanschitzjuliav myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT kamlmanuela myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT pfauslerbettina myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT helbokraimund myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT wildnersophie myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT widmanngerlig myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT sahanicsabina myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT deisenhammerflorian myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT loscherwolfgangn myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT reindlmarkus myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT lofflerraggjudith myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup AT beerronny myastheniccrisisfollowingsarscov2infectionanddelayedvirusclearanceinapatienttreatedwithrituximabclinicalcourseand6monthfollowup |